Lv1
20 积分 2023-01-01 加入
Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma
13天前
已完结
Beyond sleep disturbance: Structured analysis of sleep habits, chronotype and sleep disorders in adults with glioma. A cross-sectional exploratory study
20天前
已完结
PAC-1 Synergizes with Sunitinib to Enhance Cell Death in Pancreatic Neuroendocrine Tumors
1个月前
已完结
Trends in target novelty in oncology R&D
1个月前
已完结
Cancer Biology and Its Treatment Modalities: A Brief Historical Perspective
1个月前
已完结
Trends in target novelty in oncology R&D
1个月前
已完结
Increasing FDA-accelerated approval of single-arm trials in oncology (1992 to 2020)
1个月前
已完结
Breakthrough therapy designations in China and the United States
1个月前
已完结
Homeostasis
1个月前
已关闭
Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib
1个月前
已完结
皖公网安备34019202002308
